Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland

被引:100
作者
Sajduda, A
Brzostek, A
Poplawska, M
Augustynowicz-Kopec, E
Zwolska, Z
Niemann, S
Dziadek, J
Hillemann, D
机构
[1] Polish Acad Sci, Ctr Med Biol, PL-93232 Lodz, Poland
[2] Natl Res Inst Tuberculosis & Lung Dis, Dept Microbiol, Warsaw, Poland
[3] Forschungszentrum Borstel, Natl Ref Ctr Mycobacteria, Borstel, Germany
关键词
D O I
10.1128/JCM.42.6.2425-2431.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 105 rifampin (RMP)- and/or isoniazid (INH)-resistant strains of Mycobacterium tuberculosis isolated from different parts of Poland in 2000 were screened for mutations associated with resistance to these drugs by two molecular methods, namely sequence analysis and real-time PCR technology. Three loci associated with drug resistance were selected for characterization: they were rpoB (RMP), katG, and the regulatory region of inhA (INH). Nineteen different mutations were identified in 64 RMP-resistant strains, and five new alleles were described. The most common point mutations were in codons 531 (41%), 516 (16%), and 526 (9%) of the rpoB gene. Mutations were not found in two (3%) of the isolates. In the case of resistance to INH, six different mutations in the katG gene of 83 resistant strains were detected. Fifty-seven (69%) isolates exhibited nucleotide substitutions at codon 315. One strain harbored a mutation affecting codon 279 (Gly279Thr). Twelve of 26 INH-resistant strains with the wild-type codon 315 (14.5% of all strains tested) had the mutation -15C-->T in the regulatory region of inhA. A full correlation between the DNA sequence analysis and real-time PCR data was obtained. We conclude that the real-time PCR method is fast and reliable for the detection of RMP and INH resistance-associated mutations in M. tuberculosis clinical isolates.
引用
收藏
页码:2425 / 2431
页数:7
相关论文
共 29 条
[1]  
Augustynowicz-Kopec E, 2003, INT J TUBERC LUNG D, V7, P645
[2]   Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania [J].
Bakonyte, D ;
Baranauskaite, A ;
Cicenaite, J ;
Sosnovskaja, A ;
Stakenas, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) :2009-2011
[3]   Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay [J].
Bártfai, Z ;
Somoskövi, A ;
Ködmön, C ;
Szabó, N ;
Puskás, E ;
Kosztolányi, L ;
Faragó, E ;
Mester, J ;
Parsons, LM ;
Salfinger, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3736-3739
[4]   Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from turkey by DNA sequencing and line probe assay [J].
Cavusoglu, C ;
Hilmioglu, S ;
Guneri, S ;
Bilgic, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (12) :4435-4438
[5]   Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis [J].
Edwards, KJ ;
Metherell, LA ;
Yates, M ;
Saunders, NA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) :3350-3352
[6]   Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons [J].
El-Hajj, HH ;
Marras, SAE ;
Tyagi, S ;
Kramer, FR ;
Alland, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :4131-4137
[7]   New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis [J].
Garcia de Viedma, D ;
Infantes, MDD ;
Lasala, F ;
Chaves, F ;
Alcalá, L ;
Bouza, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :988-995
[8]  
Gonzalez N., 1999, Tubercle and Lung Disease, V79, P187, DOI 10.1054/tuld.1998.0195
[9]   Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates [J].
Heep, M ;
Brandstätter, B ;
Rieger, U ;
Lehn, N ;
Richter, E ;
Rüsch-Gerdes, S ;
Niemann, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :107-110
[10]   Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis [J].
Heep, M ;
Rieger, U ;
Beck, D ;
Lehn, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :1075-1077